Dr. Linus S. Lin is currently VP-China Research of Eli Lilly & Co.  He leads the newly created Lilly China Innovation and Partnerships, a group that is designed to engage industry and academic collaborators in China to accelerate innovation and catalyze value creation.

Prior to Lilly, Dr. Lin was Vice President of Operations and Chemistry and Global Head of Chemistry Technology and Services at WuXi AppTec. He led a business unit of over 1500 scientists, established/maintained business collaborations that included every major pharma company and 100s of biotech/non-profit/academic research institutions, and helped to build the top discovery CRO brand in the industry.

Dr. Lin started his industry career as a medicinal chemist at Merck Research Laboratories, rising to Global Chemistry Operations Lead. He was also a founding member of the External Basic Research unit at Merck, which was tasked to deliver a quarter of the discovery pipeline through external collaborations. Over a 15-year span at Merck, he led multiple drug discovery teams delivering 9 preclinical candidates, including 4 completing PhI studies and one completing PhIII studies.

Dr. Lin entered Peking University at the age of 15 and received his BS in Chemistry four years later. He then obtained his PhD in Organic Chemistry at the University of Wisconsin-Madison, and completed his NIH postdoctoral Fellowship with Nobel laureate Prof. E. J. Corey at Harvard University. His scientific contributions included 120+ peer-reviewed manuscripts and published patents. Over his career, he enjoyed building high performance teams, fostering cross-division/cross-company collaborations, and delivering value to all stake holders.